Singfiller欣菲聆品牌怎么样 申请店铺

我要投票 Singfiller欣菲聆在玻尿酸行业中的票数:64 更新时间:2024-12-22
Singfiller欣菲聆是哪个国家的品牌?「Singfiller欣菲聆」是 杭州协合医疗用品有限公司 旗下著名品牌。该品牌发源于浙江,由创始人沈晶在2003期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
Singfiller欣菲聆怎么样

2002年,在富阳新登,杭州协合医疗用品有限公司迈出了属于它的第一步。至此,拉开了协合医疗十年发展的大幕。2003年协合医疗迁至富阳高桥工业园区,陆续建起万级净化车间2个、质检中心和研发中心各1个,仓库楼、宿舍楼各一幢,初步实现了由微小企业向中小型企业的过渡。

2011年协合医疗收购海纳医疗(杭州)有限公司,总投资3个亿,开始建设协合医疗下沙新基地,一期已经建成1.7万平方米的标准化厂房,2000平方米的GMP净化车间3个、4000平方米的物流中心、1000平方米的研发及质检中心,可生产各类医疗器械1200余万套,实现产能25亿人民币。截止2013年,协合医疗已拥有下沙、富阳、南昌三个生产基地,杭州、北京、上海、南昌、广州、成都、重庆、福州8个医学营销中心,北京、上海两家医学会展及培训公司,集团员工400余人,年产各类医疗械200多万套,年销售逾5亿人民币,成功实现由创业阶段向快速发展阶段的转型。

协合医疗目前有八大系列产品,每年50余种医疗器械产品销往30个省市,用户达1000余家,部分产品远销往全球40多个国家,如:意大利、俄罗斯、土耳其、法国、巴西、智利、澳大利亚、加拿大。作为以发展新型复合与智能型材料为方向的杭州协合医疗用品有限公司来说,它的坚持,正在备受认可。

协合医疗构建了与国际同步的可吸收生物材料研发平台,在防粘连、止血、微整形材料、组织工程基础材料领域已获得10余项专利,另有多项专利正在申报中。当然,除了产品的研发,严格的质量控制也是企业赖以生存的根本,协合医疗遵循“质量第一、管理优先、建和谐企业、创协合品牌”的质量方针,生产车间采用当代先进的制药工艺生产线和在线监控设备,以确保持续生产出符合国家食品药品监督管理总局(CFDA)法规要求和欧盟MDD指令的第三类医疗器械、药品注射剂产品。越来越多的荣誉,越来越多的新技术,越来越成熟的发展模式,杭州协合医疗用品有限公司正在一步步成为中国可吸收生物材料领域的领军者。

In 2002, in Xindeng, Fuyang, Hangzhou Xiehe Medical Supplies Co., Ltd. took its first step. So far, it has opened the curtain of the development of cooperative medical treatment in the past ten years. In 2003, Xiehe Medical moved to Fuyang Gaoqiao Industrial Park, successively built two 10000 level purification workshops, one quality inspection center and one R & D center, one warehouse building and one dormitory building, initially realizing the transition from small and medium-sized enterprises to small and medium-sized enterprises. In 2011, Xiehe Medical purchased Haina medical (Hangzhou) Co., Ltd. with a total investment of 300 million yuan, and started to build a new base of Xiehe Medical in Xiasha. In phase I, 17000 square meters of standardized factory buildings, 2000 square meters of GMP purification workshops, 4000 square meters of logistics centers and 1000 square meters of R & D and quality inspection centers have been built, which can produce more than 12 million sets of various medical devices and achieve a production capacity of 2.5 billion yuan RMB. As of 2013, Xiehe Medical Co., Ltd. has three production bases in Xiasha, Fuyang and Nanchang, eight medical marketing centers in Hangzhou, Beijing, Shanghai, Nanchang, Guangzhou, Chengdu, Chongqing and Fuzhou, two medical exhibition and training companies in Beijing and Shanghai, with more than 400 employees, an annual production of more than 2 million sets of various medical devices, and an annual sales of more than 500 million yuan. It has successfully realized the transformation from the entrepreneurial stage to the fast stage Transformation of rapid development stage. At present, Xiehe Medical has eight series of products, more than 50 kinds of medical device products are sold to 30 provinces and cities every year, with more than 1000 users. Some products are exported to more than 40 countries around the world, such as Italy, Russia, Turkey, France, Brazil, Chile, Australia and Canada. Hangzhou Xiehe Medical Supplies Co., Ltd., which aims to develop new composite and intelligent materials, is being recognized for its persistence. Synergetic medical has built an internationally synchronized research and development platform for absorbable biomaterials. It has obtained more than 10 patents in the fields of anti adhesion, hemostasis, micro plastic materials and basic materials for tissue engineering, and many other patents are under application. Of course, in addition to product research and development, strict quality control is also the foundation for the survival of enterprises. Xiehe Medical follows the quality policy of "quality first, management first, building a harmonious enterprise and creating Xiehe brand". The production workshop adopts the modern advanced pharmaceutical process production line and on-line monitoring equipment to ensure the continuous production in line with the State Food and Drug Administration (CFDA) Class III medical devices and drug injection products required by regulations and EU MDD directives. With more and more honors, more and more new technologies and more mature development models, Hangzhou Xiehe Medical Supplies Co., Ltd. is becoming the leader in the field of absorbable biomaterials in China step by step.

本文链接: https://brand.waitui.com/8f8f64f88.html 联系电话:057163431868

千城特选小程序码

7×24h 快讯

小鹏汽车澳大利亚首家门店开业

36氪获悉,12月21日,小鹏汽车宣布其澳大利亚首家门店开业,现场主要展示了小鹏G6 SUV车型及小鹏飞行汽车。此前,小鹏汽车表示小鹏G6大规模发往澳洲。

57分钟前

长安汽车与亿航智能签订飞行汽车合作协议

36氪获悉,12月21日,长安汽车全球科学与艺术中心现场推进暨飞行汽车合作签约活动举行。长安汽车与亿航智能签订了飞行汽车合作协议,双方将对飞行汽车整机等关键技术进行联合攻关,探索研究具有未来感、科技感的产品,布局飞行汽车应用场景,推动商业化进程。

57分钟前

天邦食品:与厦门建发及正虹科技签订饲料合作协议

36氪获悉,12月20日,厦门建发、正虹科技及天邦食品就饲料合作举行会谈并签署相关协议。根据合作协议,厦门建发将根据天邦食品的需求,将原料供应给正虹科技,由正虹科技将加工好的饲料供应给天邦食品。未来,正虹与天邦还计划通过天邦下属的“嗨客猪管家”托管业务,共同运营闲置猪场。

57分钟前

B站举办第七届国创发布会:持续扶持原创动画,斩获全球近400项大奖

12月21日,哔哩哔哩举办了2024-2025年国创动画作品发布会,公布了43部国创作品。据了解,原创动画依然是B站的重点投入对象,本次B站公布了12部原创动画,占比超过25%。B站扶持动画创作者的专项计划“寻光”也取得了超预期的成绩,计划衍生作品《胶囊计划》系列,目前已入围并收获全球373项专业奖项。2018年至今,B站累计播出国创作品642部,出品原创动画达78部,用户观看时长近6.6亿,互动总数超过2.5亿,用户规模更达到约3.2亿。

57分钟前

蔚来汽车新品牌“萤火虫”预售价14.88万元 2025年4月上市

36氪获悉,12月21日蔚来汽车宣布,新品牌firefly萤火虫的中国市场预售价14.88万元,将在2025年4月正式上市。

57分钟前

本页详细列出关于Singfiller欣菲聆的品牌信息,含品牌所属公司介绍,Singfiller欣菲聆所处行业的品牌地位及优势。
咨询